Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs

In this work the experimental metabolic syndrome on the basis of protamine sulfate modeling in guinea pigs was reproduced and pathological processes in the liver of experimental animals were studied. We determined the level of free radicals and markers of liver damage in the blood of experimental an...

Full description

Bibliographic Details
Main Authors: V. V. Rushchak, M. O. Chashchyn
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2016-04-01
Series:The Ukrainian Biochemical Journal
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2016/04/Rushchak_2_16.pdf
_version_ 1797427762928025600
author V. V. Rushchak
M. O. Chashchyn
author_facet V. V. Rushchak
M. O. Chashchyn
author_sort V. V. Rushchak
collection DOAJ
description In this work the experimental metabolic syndrome on the basis of protamine sulfate modeling in guinea pigs was reproduced and pathological processes in the liver of experimental animals were studied. We determined the level of free radicals and markers of liver damage in the blood of experimental animals. We investigated the liver glycogen content and K+,Na+-ATPase activity in the liver of experimental animals as well as measured the cytochrome P450 2E1 (CYP2E1) expression – one of the main factors of oxidative stress. Evidence of development of hepatotoxic processes, increasing of the CYP2E1 level as well as of the free radical level in the animals with metabolic syndrome were found. Using of CYP2E1 inhibitors had shown that the free radical level in the blood of experimental animals depended on the level of the enzyme expression and activity. The obtained results suggest that the changes in the CYP2E1 expression play an important role in the development of hepatotoxic processes upon experimental metabolic syndrome. It was assumed that pharmacological correction of the enzyme expression may be an important mechanism for the influence on the metabolic syndrome clinical course.
first_indexed 2024-03-09T08:49:45Z
format Article
id doaj.art-293edf0eca044e6bb611beaef73eeca5
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-09T08:49:45Z
publishDate 2016-04-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-293edf0eca044e6bb611beaef73eeca52023-12-02T14:35:55ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032016-04-018829810610.15407/ubj88.02.098Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigsV. V. Rushchak0M. O. Chashchyn1Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, KyivInstitute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, KyivIn this work the experimental metabolic syndrome on the basis of protamine sulfate modeling in guinea pigs was reproduced and pathological processes in the liver of experimental animals were studied. We determined the level of free radicals and markers of liver damage in the blood of experimental animals. We investigated the liver glycogen content and K+,Na+-ATPase activity in the liver of experimental animals as well as measured the cytochrome P450 2E1 (CYP2E1) expression – one of the main factors of oxidative stress. Evidence of development of hepatotoxic processes, increasing of the CYP2E1 level as well as of the free radical level in the animals with metabolic syndrome were found. Using of CYP2E1 inhibitors had shown that the free radical level in the blood of experimental animals depended on the level of the enzyme expression and activity. The obtained results suggest that the changes in the CYP2E1 expression play an important role in the development of hepatotoxic processes upon experimental metabolic syndrome. It was assumed that pharmacological correction of the enzyme expression may be an important mechanism for the influence on the metabolic syndrome clinical course.http://ukrbiochemjournal.org/wp-content/uploads/2016/04/Rushchak_2_16.pdf
spellingShingle V. V. Rushchak
M. O. Chashchyn
Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
The Ukrainian Biochemical Journal
title Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
title_full Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
title_fullStr Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
title_full_unstemmed Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
title_short Cytochrome P450 2E1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
title_sort cytochrome p450 2e1 participation in the pathogenesis of experimental metabolic syndrome in guinea pigs
url http://ukrbiochemjournal.org/wp-content/uploads/2016/04/Rushchak_2_16.pdf
work_keys_str_mv AT vvrushchak cytochromep4502e1participationinthepathogenesisofexperimentalmetabolicsyndromeinguineapigs
AT mochashchyn cytochromep4502e1participationinthepathogenesisofexperimentalmetabolicsyndromeinguineapigs